SV Biotech Crossover
Venture capitalLondon · 3 people tracked
Find your way into SV Biotech Crossover
✨ Fox Verdict
Sign up to see your fitFund manager profile
SV Biotech Crossover is a venture fund manager based in London. SEC filings show 1 venture fund on record, most recently SV Biotech Crossover Opportunities Fund LP ($350M offering) filed January 2022.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
HQ
London
Founded
2021
Team · 3 people
from public directoriesFund performance · per public LP disclosures
as of Jun 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| SV Biotech Crossover Opportunities Fund LPLPs: New Mexico Educational Retirement Board | 2024 | — | 83.8% | 1.99x | 1.21x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- Where is SV Biotech Crossover located?
- SV Biotech Crossover is headquartered in London.